SRRK Stock Gains After Company Drops Troubled Novo Nordisk-Owned Plant From FDA Filing
Scholar Rock still expects a decision on its application by the September 30 target date. In September 2025,…
Novo Nordisk Launches 450-Person Trial to Find Lowest Effective Wegovy Pill Dose — BigGo Finance
Novo Nordisk (NVO) has initiated a late-stage clinical trial to determine whether lower doses of its oral Wegovy…
Novo Nordisk launches once-weekly insulin Awiqli in US market
Danish pharmaceutical company ‘Novo Nordisk’ has launched a once-weekly insulin injection in the US market. EPA/MARTIN DIVISEK/Yonhap News…
Novo Nordisk Faces a Two-Pronged Test: Quarterly Results and a Pivotal FDA Decision
The Danish pharmaceutical giant Novo Nordisk enters a defining stretch this week, with its second-quarter earnings due on…
Novo Nordisk’s Two-Stage Catalyst: Earnings Due August 5 as CagriSema FDA Verdict Hovers
Novo Nordisk is entering a defining stretch of the year, with two pivotal events that could reshape the…
Novo Nordisk CEO Dustar: Obesity Has Eclipsed Diabetes at ADA as Lilly’s Retatrutide Hits 28.3% Weight Loss — BigGo Finance
When the chief executive of the world’s most valuable obesity-drug company admits he’s surprised that a diabetes conference…
Novo Nordisk’s 20% Rally Masks a Fundamental Gap and an FDA Clock That Hasn’t Run Out
Novo Nordisk has clawed back nearly a fifth of its value in the past month, closing Friday at…
Novo Nordisk Balances a $25M Ransom Demand and a High-Stakes FDA Decision as Shares Rebound
Novo Nordisk has clawed back more than a third of its value from March lows, yet the Danish…
Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care
Novo Nordisk A/S Novo Nordisk launches Wegovy® pill in the United Arab Emirates today Wegovy® pill is indicated…
Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care
Novo Nordisk A/S Novo Nordisk launches Wegovy® pill in the United Arab Emirates today Wegovy® pill is indicated…
Novo Nordisk’s Oral Wegovy Defies Gravity as FDA Poised to Curb Compounders
Novo Nordisk’s new Wegovy pill generates 2.26B DKK in Q1, double forecasts; revenue jumps 32% to 96.82B DKK.…
FDA Crackdown and Oral Ozempic Launch Set Stage for Earnings
Novo Nordisk enters a pivotal week with an FDA shortage-list victory, oral Ozempic rollout, and partnerships to capture…